Insmed PARI milestones — Intangible Amortization increased by 1.0% to $51.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.0%, from $50.50K to $51.00K. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase reflects the ongoing consumption of asset value, which reduces reported net income without impacting cash flow.
This represents the periodic expense recognized to allocate the cost of PARI-related intangible assets over their estima...
Comparable to 'Amortization of Acquired Intangibles' found in the operating expenses of most pharmaceutical companies.
insm_segment_pari_milestones_amortization_of_intangible_assets| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $50.50K | $50.50K | $50.50K | $50.50K | $50.50K | $50.50K | $50.50K | $50.50K | $51.00K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +1.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +1.0% |